These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28525328)

  • 1. Establishment of 5-Fluorouracil-resistant canine mammary tumor cell line.
    Zhou B; Zhang D; Pei SM; Zhang H; Du HC; Jin YP; Lin DG
    Pol J Vet Sci; 2017 Mar; 20(1):103-110. PubMed ID: 28525328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and resistance mechanisms of a 5-fluorouracil- resistant hepatocellular carcinoma cell line.
    Gu W; Fang FF; Li B; Cheng BB; Ling CQ
    Asian Pac J Cancer Prev; 2012; 13(9):4807-14. PubMed ID: 23167424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of a multidrug-resistant cell line BEL-7402/5-FU of human hepatocellular carcinoma and its biological characteristics].
    Gu W; Zhang YN; Li B; Han J; Cheng BB; Ling CQ
    Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):265-70. PubMed ID: 16696913
    [TBL] [Abstract][Full Text] [Related]  

  • 4.  Thymosin β10 as a predictive biomarker of response to 5-fluorouracil chemotherapy in cholangiocarcinoma.
    Sribenja S; Natthasirikul N; Vaeteewoottacharn K; Sawanyawisuth K; Wongkham C; Jearanaikoon P; Wongkham S
    Ann Hepatol; 2016; 15(4):577-85. PubMed ID: 27236157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of 5-fluorouracil-resistant oral squamous cell carcinoma cell lines with epithelial to mesenchymal transition changes.
    Harada K; Ferdous T; Ueyama Y
    Int J Oncol; 2014 Apr; 44(4):1302-8. PubMed ID: 24452635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment, characterization, and biological analysis of pancreatic adenocarcinoma cell strain SW1990/FU].
    Guo JC; Zhao YP; Liao Q; Chen G; Zhang LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):592-6. PubMed ID: 16274039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-27a modulates the MDR1/P-glycoprotein expression by inhibiting FZD7/β-catenin pathway in hepatocellular carcinoma cells.
    Chen Z; Ma T; Huang C; Zhang L; Lv X; Xu T; Hu T; Li J
    Cell Signal; 2013 Dec; 25(12):2693-701. PubMed ID: 24018051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
    Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
    Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line.
    Han Y; Bu LM; Ji X; Liu CY; Wang ZH
    Chin J Dig Dis; 2005; 6(2):82-6. PubMed ID: 15904426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402/5-FU cells.
    Gu W; Liu L; Fang FF; Huang F; Cheng BB; Li B
    Oncol Rep; 2014 Jan; 31(1):216-22. PubMed ID: 24173654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
    Lu F; Hou YQ; Song Y; Yuan ZJ
    Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New uracil analogs as downregulators of ABC transporters in 5-fluorouracil-resistant human leukemia HL-60 cell line.
    Długosz-Pokorska A; Pięta M; Janecki T; Janecka A
    Mol Biol Rep; 2019 Dec; 46(6):5831-5839. PubMed ID: 31741260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
    Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
    IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The upregulation of dihydropyrimidine dehydrogenase in liver is involved in acquired resistance to 5-fluorouracil.
    Li LH; Dong H; Zhao F; Tang J; Chen X; Ding J; Men HT; Luo WX; Du Y; Ge J; Tan BX; Cao D; Liu JY
    Eur J Cancer; 2013 May; 49(7):1752-60. PubMed ID: 23313143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoresistance to 5-fluorouracil induces epithelial-mesenchymal transition via up-regulation of Snail in MCF7 human breast cancer cells.
    Zhang W; Feng M; Zheng G; Chen Y; Wang X; Pen B; Yin J; Yu Y; He Z
    Biochem Biophys Res Commun; 2012 Jan; 417(2):679-85. PubMed ID: 22166209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response.
    Matsuyama R; Togo S; Shimizu D; Momiyama N; Ishikawa T; Ichikawa Y; Endo I; Kunisaki C; Suzuki H; Hayasizaki Y; Shimada H
    Int J Cancer; 2006 Jul; 119(2):406-13. PubMed ID: 16477629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance.
    Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG
    Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery.
    De Angelis PM; Svendsrud DH; Kravik KL; Stokke T
    Mol Cancer; 2006 May; 5():20. PubMed ID: 16709241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks.
    Wang W; McLeod HL; Cassidy J; Collie-Duguid ES
    Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan-graft poly(caprolactone)-based nanoparticles.
    Shi WB; Le VM; Gu CH; Zheng YH; Lang MD; Lu YH; Liu JW
    J Pharm Sci; 2014 Apr; 103(4):1064-74. PubMed ID: 24523221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.